Anker; Stefan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Anker; Stefan.The latest application filed is for "s-enantiomerically enriched compositions of beta blockers for treating muscle weakness".

Company Profile

8.21.25

Anker; Stefan - Berlin DE
Anker; Stefan - Abingdon GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oxprenolol compositions for treating cancer Grant 11,433,036 - Coats , et al. September 6, 2	2022-09-06
S-enantiomerically enriched compositions of beta blockers for treating muscle weakness Grant 11,382,876 - Anker , et al. July 12, 2	2022-07-12
S-enantiomerically Enriched Compositions Of Beta Blockers For Treating Muscle Weakness App 20210346320 - Anker; Stefan ; et al.	2021-11-11
S-enantiomerically Enriched Compositions Of Beta Blockers For Treating Amyotrophic Lateral Sclerosis App 20210330615 - COATS; Andrew J.S. ; et al.	2021-10-28
S-enantiomerically enriched compositions of beta blockers for treating muscle weakness Grant 11,096,908 - Anker , et al. August 24, 2	2021-08-24
Oxprenolol Compositions For Treating Cancer App 20210251924 - Coats; Andrew J.S. ; et al.	2021-08-19
S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis Grant 11,007,158 - Coats , et al. May 18, 2	2021-05-18
Oxprenolol compositions for treating cancer Grant 10,828,270 - Coats , et al. November 10, 2	2020-11-10
S-enantiomerically Enriched Compositions Of Beta Blockers For Treating Muscle Weakness App 20200230080 - Anker; Stefan ; et al.	2020-07-23
S-enantiomerically Enriched Compositions Of Beta Blockers For Treating Amyotrophic Lateral Sclerosis App 20200054585 - COATS; Andrew J.S. ; et al.	2020-02-20
S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis Grant 10,449,166 - Coats , et al. Oc	2019-10-22
Oxprenolol compositions for treating cancer Grant 10,398,658 - Coats , et al. Sep	2019-09-03
Oxprenolol Compositions For Treating Cancer App 20190054043 - Coats; Andrew J.S. ; et al.	2019-02-21
S-enantiomerically Enriched Compositions Of Beta Blockers For Treating Muscle Weakness App 20190046476 - Anker; Stefan ; et al.	2019-02-14
Selective AT2 receptor agonists for use in treatment of cachexia Grant 10,016,397 - Springer , et al. July 10, 2	2018-07-10
Selective At2 Receptor Agonists For Use In Treatment Of Cachexia App 20160175286 - Springer; Jochen ; et al.	2016-06-23
Use of Megestrol Acetate for Improving Heart Function and the Treatment of Heart Insufficiency App 20160101117 - ANKER; Stefan	2016-04-14
Oxprenolol Compositions For Treating Cancer App 20160022612 - Coats; Andrew J.S. ; et al.	2016-01-28
S-enantiomerically Enriched Compositions Of Beta Blockers For Treating Amyotrophic Lateral Sclerosis App 20160022613 - COATS; Andrew J.S. ; et al.	2016-01-28
Prevention and treatment of sarcopenia Grant 8,835,485 - Springer , et al. September 16, 2	2014-09-16
Method of Treating Cachexia and Sarcopenia App 20140194484 - Coats; Andrew ; et al.	2014-07-10
Method for enhancing the performance and general condition of a subject Grant 8,655,445 - Anker February 18, 2	2014-02-18
Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease Grant 8,647,830 - Bergmann , et al. February 11, 2	2014-02-11
Method For Enhancing The Performance And General Condition Of A Subject App 20130267797 - ANKER; Stefan	2013-10-10
Method for enhancing the performance and general condition of a subject Grant 8,483,824 - Anker July 9, 2	2013-07-09
Use Of Megestrol Acetate For Improving Heart Function And The Treatment Of Heart Insufficiency App 20130143848 - ANKER; STEFAN	2013-06-06
Use of megestrol acetate for improving heart function and the treatment of heart insufficiency Grant 8,383,612 - Anker February 26, 2	2013-02-26
Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients Grant 8,252,544 - Bergmann , et al. August 28, 2	2012-08-28
Prevention And Treatment Of Sarcopenia App 20120095070 - Springer; Jochen ; et al.	2012-04-19
Method For Determining Amino-terminal Proanp In Patients Having A Cardiac Disease Or Being Suspected Of Developing Or Having A Cardiac Disease App 20100285493 - Bergmann; Andreas ; et al.	2010-11-11
Diagnosis And Risk Stratification Of Cardiac Insufficiency By Means Of Natriuretic Peptides For Nyha I Patients App 20100143953 - Bergmann; Andreas ; et al.	2010-06-10
Method For Enhancing The Performance And General Condition Of A Subject App 20090248101 - Anker; Stefan	2009-10-01
Therapy And Use Of Compounds In Therapy App 20090197851 - Anker; Stefan ; et al.	2009-08-06
Use of Megestrol Acetate for the Treatment of Obstructive Pulmonary Diseases App 20080269179 - Anker; Stefan ; et al.	2008-10-30
Use of Megestrol Acetate for Improving Heart Function and the Treatment of Heart Insufficiency App 20080139521 - Anker; Stefan	2008-06-12
Therapy and Use of Compounds in Therapy App 20070197485 - Anker; Stefan ; et al.	2007-08-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.